Mandatory use of ISO/ICH E2B(R3) Individual Case Safety Reporting inthe EU: Hands-on training course using the EudraVigilance System, Online, from 15 June 2026 to 19 June 2026
Mandatory use of ISO/ICH E2B(R3) Individual Case Safety Reporting inthe EU: Hands-on training course using the EudraVigilance System, Online, from 26 January 2026 to 30 January 2026
Draft user manual for the eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) user interface (XEVMPDweb)
EMA/PE/0000183758
Opinion/decision on a Paediatric investigation plan (PIP): Adtralza, tralokinumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0012/2024
Opinion/decision on a Paediatric investigation plan (PIP): Rxulti, brexpiprazole, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Psychiatric disorders, PIP number: EMA/PE/0000183866
EMA/PE/0000184400
EMA/PE/0000183220
EMEA-002944-PIP01-20
EMEA-003104-PIP02-22